Last reviewed · How we verify
Blood clot scaffold
At a glance
| Generic name | Blood clot scaffold |
|---|---|
| Sponsor | Nourhan M.Aly |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Single Versus Multiple Visits Regenerative Endodontics in Mature Teeth (NA)
- Autogenous Tooth Transplantation With Instrumentally Simulated Open Apex and Platelet-Rich Fibrin (NA)
- Success of Endodontic Regenerative Approaches in Anterior and Posterior Immature Non Vital Teeth (NA)
- PRF and CGF Scaffolds With EDTA in Regeneration (NA)
- Comparison Between Emdogain and Amniotic Membrane as a Scaffold in Endodontic Regeneration of Immature Anterior Teeth (NA)
- AMIC Compared With Microfracture for Focal Articular Cartilage Damage of the Hip (PHASE1)
- A Study of Collagen Scaffold for the Repair of Elbow Cartilage Injury (PHASE3)
- Clinical and Radiographic Outcomes of PRF, Chitosan, and Blood Clot in Regenerative Endodontics of Molars (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Blood clot scaffold CI brief — competitive landscape report
- Blood clot scaffold updates RSS · CI watch RSS
- Nourhan M.Aly portfolio CI